Congratulations to the brilliant Astrid Weins for her pioneering work in discovering the role of Antinephrin antibodies!

Nice to meet old friends from Japan in Stockholm #ERA24 ⁦Seiji Kishi, MD, PhD, FACP⁩ ⁦Takuhiro Moromizato⁩

One whole session on kidney fibrosis with speakers only from Aachen at #ERA24 RWTH Aachen Uniklinik RWTH AC lots of unpublished data 🔥🔥🔥LaBooratory Sikander Hayat

Thanks #ERA24 organisers for this opportunity. It was such an amazing experience talking about our synergistic efforts to understand kidney fibrosis. And thanks for creating this collaborative ecosystem in Aachen!

Excited to continue our work on vascular calcification in this new Foundation Leducq network COMET with terrific partners

Honored that Foundation Leducq has funded our Network, COMET: Calcification-Omics, Molecular Elucidation & Therapeutics. What a wonderful team of scientists to work alongside including Cathy Shanahan, Clint Miller Rafael Kramann, MD PhD Yabing Chen, Melinda Duer, Maryam Kavousi

Great meeting of the Czech Society of Nephrology in Prague with many collaborators and friends next stop Vienna for the European Congress of Rheumathology EULAR exciting science and trials 🔥🔥

Terrific to see so many young kidney researchers in Munich !

You know your husband is a nephrologist when your kids evaluate the color of their urine every time they go to the bathroom 😅Rafael Kramann, MD PhD #kidneydiseaseawareness

💃🌟🧑‍💻Exciting talks by Dr. Shruti Naik Longaker Lab JHElisseeff Rachel Chambers Rafael Kramann, MD PhD and more!

Check out our work led by Turgay Saritas and Xiaohang Shao: Generation of a conditional cellular senescence model using proximal tubule cells and fibroblasts from human kidneys out today nature.com/articles/s4142…

📣 The much-revised manuscript of LIANA+, our all-in-one solution to study cell-cell communication from single-cell, spatial, and multi-omics technologies, is now published in Nature Cell Biology nature.com/articles/s4155…

Hamburg news: Uncovering mTOR-independent signaling in cystic kidney disease. Study led by Florian Grahammer including Freiburg-, Hamburg- and international teams. Victor Puelles Rafael Kramann, MD PhD Beno Freedman Uniklinik Freiburg Universität Hamburg UKE Hamburg HCKH_Hamburg pubmed.ncbi.nlm.nih.gov/39218392/